Skip to content
GLP-1 Decoder

Ozempic Long-Term Side Effects: What Years of Data Show

Ozempic has been sold in the US since 2017. The long-term label warnings are thyroid C-cell tumors (seen in rodents), pancreatitis, gallbladder disease and kidney injury from fluid loss.

Sold in the US since
2017
Most common
Nausea 20.3%
Same on placebo
6.1%
Trial group
Adults with type 2 diabetes

Ozempic overview

Time in the body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week: after 7 d, half is gone, and about 3% remains after five half-lives (35 d).

Main-trial weight loss
Ozempic (SUSTAIN 1)4.7 kgPlacebo1.2 kg

In SUSTAIN 1, people with type 2 diabetes lost 4.7 kg over 30 weeks, compared with 1.2 kg on placebo.

Prices over time
202520262027$1,027.51$0List priceSelf-pay

Monthly prices in US dollars include the list price and self-pay offers, all taken from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

Serious warnings in plain words

Source: FDA label (DailyMed).

Source: FDA label (DailyMed).

Long term side effects of Ozempic: label rates vs placebo

The FDA label lists 5 common Ozempic side effects identified in placebo-controlled trials. In the last column, you can see how much more often each one appeared than it did on placebo.

Table 1. Placebo-Controlled Trials Reported: Adverse Reactions in ≥5% of OZEMPIC-Treated Patients with Type 2 Diabetes Mellitus
Side effectPlaceboOzempic 0.5 mgOzempic 1 mgMore than placebo, 1 mg
Nausea6.1%15.8%20.3%+14.2 points
Vomiting2.3%5%9.2%+6.9 points
Diarrhea1.9%8.5%8.8%+6.9 points
Abdominal pain4.6%7.3%5.7%+1.1 points
Constipation1.5%5%3.1%+1.6 points

Source: FDA label (DailyMed).

Who experiences more side effects than others